Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 17 of about 17 for Genentech Inc.�
Company Exchange Symbol Last price Quote change Market cap
PDL BioPharma Inc NASDAQ PDLI 5.67 -0.05 (-0.87%) 938.61M
PDL BioPharma, Inc., manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents, license agreements with various ...
Biogen Inc NASDAQ BIIB 330.38 +6.00 (1.85%) 76.28B
Biogen Inc., formerly Biogen Idec Inc., is a global biopharmaceutical company. The Company is focused on discovering, developing, manufacturing and ...
ImmunoGen, Inc. NASDAQ IMGN 16.33 -0.30 (-1.80%) 1.43B
ImmunoGen, Inc. is a biotechnology company. The Company develops targeted anticancer therapeutics. The Company has three wholly-owned product candidates in ...
Genentech, Inc. Private
... human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, and asthma drug Xolair. Genentech is wholly owned by Swiss pharma powerhouse Roche.
Array Biopharma Inc NASDAQ ARRY 5.81 +0.12 (2.11%) 807.26M
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients ...
Exelixis, Inc. NASDAQ EXEL 6.62 +0.50 (8.17%) 1.35B
Exelixis Inc. is a biopharmaceutical company. The Company is engaged in developing small molecule therapies for the treatment of cancer.
Roche Holding AG ETR RHO5 106.90 -0.45 (-0.42%) 0.00
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Aptose Biosciences Inc NASDAQ APTO 4.48 -0.03 (-0.72%) 53.99M
Aptose Biosciences Inc. (Aptose) is a clinical stage biotechnology company. The Company is engaged in development of targeted therapies addressing unmet ...
PDL BIOPHARMA INC. DL-,01 FRA PDL 5.18 -0.07 (-1.41%)
Xenon Pharmaceuticals Inc NASDAQ XENE 10.50 +0.08 (0.77%) 148.26M
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan ...
Aptose Biosciences Inc TSE APS 5.90 -0.04 (-0.67%) 70.40M
Aptose Biosciences Inc. (Aptose) is a clinical stage biotechnology company. The Company is engaged in development of targeted therapies addressing unmet ...
BIOGEN INC. DL -,0005 FRA IDP 301.60 +5.78 (1.95%)
BIOGEN INC. DL -,0005 ETR IDP 301.30 +5.45 (1.84%)
IMMUNOGEN INC. DL-,01 FRA IMU 14.84 -1.20 (-7.46%)
EXELIXIS INC. DL-,01 FRA EX9 5.94 +0.82 (15.95%)
EXELIXIS INC. DL-,01 ETR EX9 0.0000
XENON PHARMACEUTICALS FRA XP0 9.31 -0.40 (-4.08%)